Complete Genetic Correction of iPS Cells From Duchenne Muscular Dystrophy
Open Access
- 1 February 2010
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 18 (2) , 386-393
- https://doi.org/10.1038/mt.2009.274
Abstract
No abstract availableKeywords
Funding Information
- Core Research for Evolutional Science and Technology
- Ministry of Education, Culture, Sports, Science and Technology
- Japan Science and Technology Agency
This publication has 37 references indexed in Scilit:
- Treatment of Sickle Cell Anemia Mouse Model with iPS Cells Generated from Autologous SkinScience, 2007
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- Derivation of engraftable skeletal myoblasts from human embryonic stem cellsNature Medicine, 2007
- Viral-mediated gene therapy for the muscular dystrophies: Successes, limitations and recent advancesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2007
- Construction of a novel human artificial chromosome vector for gene deliveryBiochemical and Biophysical Research Communications, 2004
- Correction of a Genetic Defect by Nuclear Transplantation and Combined Cell and Gene TherapyCell, 2002
- The complete sequence of dystrophin predicts a rod-shaped cytoskeletal proteinCell, 1988
- Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individualsCell, 1987
- Establishment in culture of pluripotential cells from mouse embryosNature, 1981
- The Cardiomyopathy of Progressive Muscular DystrophyCirculation, 1966